4//SEC Filing
Wagner Paul A. 4
Accession 0001415889-24-024494
CIK 0001419041other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 6:19 PM ET
Size
9.3 KB
Accession
0001415889-24-024494
Insider Transaction Report
Form 4
Wagner Paul A.
DirectorSEE REMARKS
Transactions
- Exercise/Conversion
Common Stock
2024-10-01+1,250→ 77,568 total - Tax Payment
Common Stock
2024-10-01$5.16/sh−98$506→ 77,470 total - Exercise/Conversion
Restricted Stock Units
2024-10-01−1,250→ 11,250 total→ Common Stock (1,250 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. (the "Issuer") Common Stock.
- [F2]The reported number of securities has been adjusted to reflect the Issuer's 1-for-25 reverse stock split effected on August 28, 2024.
- [F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, "Quarterly Vesting Date" with respect to any calendar year means January 1, April 1, July 1, and October 1.
Documents
Issuer
Forte Biosciences, Inc.
CIK 0001419041
Entity typeother
Related Parties
1- filerCIK 0001612842
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 6:19 PM ET
- Size
- 9.3 KB